Bay 43-9006 B-Raf inhibitor ase cell cycle regulators during amyotrophic

ase cell cycle regulators during amyotrophic Bay 43-9006 B-Raf inhibitor lateral sclerosis. Am J Pathol 2003,162:823 835. Rao HV, Thirumangalakudi L, Grammas P. Cyclin C and cyclin dependent kinases 1, 2 and 3 in thrombininduced neuronal cell cycle progression and apoptosis. Neurosci Lett. 2008 Rao HV, Thirumangalakudi L, Desmond P, Grammas P. Cyclin D1, cdk4, and Bim are involved in thrombin induced apoptosis in cultured cortical neurons. J Neurochem 2007,101:498 505. Resnitzky D, Gossen M, Bujard H, Reed SI. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol Cell Biol 1994,14:1669 1679. Richard Green A, Odergren T, Ashwood T. Animal models of stroke: do they have value for discovering neuroprotective agents? Trends Pharmacol Sci 2003,24:402 408. Roberds SL, et al.
BACE knockout mice are healthy despite lacking the primary beta secretase activity in brain: implications for Alzheimer,s Capecitabine disease therapeutics. Hum Mol Genet 2001,10:1317 1324. Robinson DM, Keating GM. Memantine: a review of its use in Alzheimer,s disease. Drugs 2006,66:1515 1534. Sausville EA. Cyclin dependent kinase modulators studied at the NCI: pre clinical and clinical studies. Curr Med Chem Anticancer Agents 2003,3:47 56. Schwartz GK, Shah MA. Targeting the cell cycle: a new approach to cancer therapy. J Clin Oncol 2005,23:9408 9421. Schwartz GK, Farsi K, Maslak P, Kelsen DP, Spriggs D. Potentiation of apoptosis by flavopiridol in mitomycin C treated gastric and breast cancer cells. Clin Cancer Res 1997,3:1467 1472. Segarra J, Balenci L, Drenth T, Maina F, Lamballe F.
Combined signaling through ERK, PI3K/AKT, and RAC1/p38 is required for met triggered cortical neuron migration. J Biol Chem 2006,281:4771 4778. Selkoe DJ. Folding proteins in fatal ways. Nature 2003,426:900 904. Liu et al. Page 15 Neurobiol Dis. Author manuscript, available in PMC 2011 March 1. NIH PA Author Manuscript NIH PA Author Manuscript NIH PA Author Manuscript Senderowicz AM. Flavopiridol: the first cyclin dependent kinase inhibitor in human clinical trials. Invest New Drugs 1999,17:313 320. Senderowicz AM, Sausville EA. Preclinical and clinical development of cyclin dependent kinase modulators. J Natl Cancer Inst 2000,92:376 387. Shankland SJ, Wolf G. Cell cycle regulatory proteins in renal disease: role in hypertrophy, proliferation, and apoptosis. Am J Physiol Renal Physiol 2000,278:F515 529.
Shapiro GI, Koestner DA, Matranga CB, Rollins BJ. Flavopiridol induces cell cycle arrest and p53 independent apoptosis in non small cell lung cancer cell lines. Clin Cancer Res 1999,5:2925 2938. Shen J, Xie L, Mao X, Zhou Y, Zhan R, Greenberg DA, Jin K. Neurogenesis after primary intracerebral hemorrhage in adult human brain. J Cereb Blood Flow Metab 2008,28:1460 1468. Sherr CJ, Roberts JM. Inhibitors of mammalian G1 cyclin dependent kinases. Genes Dev 1995,9:1149 1163. Smirnova IV, Citron BA, Arnold PM, Festoff BW. Neuroprotective signal transduction in model motor neurons exposed to thrombin: G protein modulation effects on neurite outgrowth, Ca mobilization, and apoptosis. J Neurobiol 2001,48:87 100. Smith PJ, Marquez N, Wiltshire M, Chappell S, Njoh K, Campbell L, Khan IA, Silvestre O, Errington RJ.
Mitotic bypass via an occult cell cycle phase following DNA topoisomerase II inhibition in p53 functional human tumor cells. Cell Cycle 2007,6:2071 2081. Sokolova E, Reiser G. Prothrombin/thrombin and the thrombin receptors PAR 1 and PAR 4 in the brain: localization, expression and participation in neurodegenerative diseases. Thromb Haemost 2008,100:576 581. Sridhar J, Akula N, Pattabiraman N. Selectivity and potency of cyclin dependent kinase inhibitors. Aaps J 2006,8:E204 221. Standridge JB. Vicious cycles within the neuropathophysiologic mechanisms of Alzheimer,s disease.

Related posts:

  1. The threonine kinases that handle cell cycle progression as therapeutic targets.
  2. Axitinib AG-013736 of a cell entering apoptosis was independent of its cell cycle stage
  3. WZ3146 Inhibition of MEK alone could induce cell
  4. DMXAA Vascular Disrupting Agent inhibitor extend this previous report and below
  5. Telaprevir around the nucleus with an eect that was substantially more extensive

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

© Apoptosis|apoptosis inhibitor|apoptosis pathway